Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article matching "May 15"

🔴 BreakingDrug approvalOPENFDAYesterday

FDA Approves BAXFENDY (BAXDROSTAT) — New Treatment Available

The FDA has approved a new drug called BAXFENDY (generic name: baxdrostat) made by AstraZeneca. This approval means the drug is now available for patients to use. The approval was granted on May 15, 2026, after the drug met safety and effectiveness standards.

WHY IT MATTERSThis is the first FDA approval of baxdrostat, but the specific rare disease indication is not detailed in this announcement — patients should check with their doctor or the FDA's full label to confirm if this drug applies to their condition.
💬 Ask your doctor

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases